Predicting Sentinel Node Status in Patients With Melanoma: Does Gene Expression Profiling Improve Accuracy?

Alexander H R Varey¹, Serigne N Lo¹, Richard A Scolyer¹+1

• ¹Alexander H. R. Varey, MBChB, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Plastic Surgery, Westmead Hospital, Westmead, NSW, Australia; Serigne N. Lo, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Richard A. Scolyer, PhD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Tissue Oncology and Diagnostic Pathology, Royal Prince Alfred Hospital and NSW Health Pathology, Camperdown, NSW, Australia; and John F. Thompson, MD, Melanoma Institute Australia and Faculty of Medicine and Health, The University of Sydney, Sydney, and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.